Clinical trial
sdAb-based Targeted Radionuclide Therapy of Multiple Myeloma: a Feasibility Study
NCT03956615 is registered in ClinicalTrials.gov with Universitair Ziekenhuis Brussel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- sdAb-based Targeted Radionuclide Therapy of Multiple Myeloma: a Feasibility Study
- Lead sponsor
- Universitair Ziekenhuis Brussel
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 12, 2019
- Completion date
- December 1, 2020
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.